Rocket


News + Filings
Transactions





MCENANY PATRICK J

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/16/2023CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock173.8k$0.79$137.3k 05/15/2023
05/15/2023CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share26.2k$13.23$346k 05/15/2023
05/15/2023CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock26.2k$0.79$20.7k 05/15/2023
12/29/2022CATALYST PHARMACEUTICALS, INC.CPRXGiftCommon stock, par value $0.001 per share10k$0.00$0 12/28/2022
12/28/2022CATALYST PHARMACEUTICALS, INC.CPRXGiftCommon stock, par value $0.001 per share10k$0.00$0 12/28/2022
12/27/2022CATALYST PHARMACEUTICALS, INC.CPRXGrantOptions to purchase common stock272k$18.59$5.1M 12/27/2022
12/27/2022CATALYST PHARMACEUTICALS, INC.CPRXGrantRestricted Stock Units79k$0.00$0 12/27/2022
12/06/2022CATALYST PHARMACEUTICALS, INC.CPRXPayment of ExerciseCommon Stock, par value $0.001 per share12.1k$0.00$0 12/06/2022
12/06/2022CATALYST PHARMACEUTICALS, INC.CPRXExerciseRestricted Stock Units30.8k$0.00$0 12/06/2022
11/21/2022CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock150k$2.24$336k 11/18/2022
11/21/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share150k$15.33$2.3M 11/18/2022
11/18/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share350k$15.62$5.5M 11/18/2022
11/18/2022CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock350k$2.24$784k 11/18/2022
09/14/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share946.8k$15.41$14.6M 09/13/2022
09/13/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share80.8k$15.33$1.2M 09/13/2022
08/19/2022CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock125k$2.53$316.2k 08/18/2022
08/19/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share125k$14.10$1.8M 08/18/2022
08/18/2022CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock25k$2.53$63.2k 08/18/2022
08/18/2022CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock50k$2.53$126.5k 08/18/2022
08/18/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share25k$13.93$348.4k 08/18/2022
08/18/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share50k$13.93$696.5k 08/18/2022
08/18/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share50k$13.96$698k 08/18/2022
08/18/2022CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share50k$13.95$697.6k 08/18/2022
02/14/2022CATALYST PHARMACEUTICALS, INC.CPRXGrantRestricted Stock Units175k$0.00$0 02/14/2022
12/28/2021CATALYST PHARMACEUTICALS, INC.CPRXGrantOptions to purchase common stock270k$7.07$1.9M 12/28/2021
12/03/2021CATALYST PHARMACEUTICALS, INC.CPRXExerciseRestricted Stock Units30.8k$0.00$0 12/03/2021
12/03/2021CATALYST PHARMACEUTICALS, INC.CPRXPayment of ExerciseCommon Stock, par value $0.001 per share12.1k$0.00$0 12/03/2021
08/23/2021CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock120k$3.12$374.4k 08/20/2021
08/23/2021CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share82.6k$5.63$464.7k 08/20/2021
08/20/2021CATALYST PHARMACEUTICALS, INC.CPRXExerciseOptions to purchase common stock80k$3.12$249.6k 08/20/2021
08/20/2021CATALYST PHARMACEUTICALS, INC.CPRXSaleCommon stock, par value $0.001 per share54.2k$5.52$298.9k 08/20/2021
12/30/2020CATALYST PHARMACEUTICALS, INC.CPRXGrantOptions to purchase common stock400k$3.42$1.4M 12/30/2020
12/22/2020CATALYST PHARMACEUTICALS, INC.CPRXExerciseRestricted Stock Units30.8k$0.00$0 12/22/2020
12/22/2020CATALYST PHARMACEUTICALS, INC.CPRXPayment of ExerciseCommon Stock, par value $0.001 per share7.5k$0.00$0 12/22/2020
09/30/2020CATALYST PHARMACEUTICALS, INC.CPRXPurchaseCommon stock, par value $0.001 per share15k$2.97$44.6k 09/30/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy